Kaye, D. M., & Raake, P. (2016). Transcatheter interatrial shunt device provides sustained clinical benefit at one year in patients with preserved or mildly reduced ejection fraction: The REDUCE LAP heart failure trial. Circulation, 134(25), . https://doi.org/10.1161/CIR.0000000000000472
Chicago-Zitierstil (17. Ausg.)Kaye, David M., und Philip Raake. "Transcatheter Interatrial Shunt Device Provides Sustained Clinical Benefit at One Year in Patients with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial." Circulation 134, no. 25 (2016). https://doi.org/10.1161/CIR.0000000000000472.
MLA-Zitierstil (9. Ausg.)Kaye, David M., und Philip Raake. "Transcatheter Interatrial Shunt Device Provides Sustained Clinical Benefit at One Year in Patients with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial." Circulation, vol. 134, no. 25, 2016, https://doi.org/10.1161/CIR.0000000000000472.